DIFFERENTIAL DIAGNOSIS OF NORMOCALCEMIC HYPERPARATHYROIDISM

Objective: to describe a case of normocalcemic hyperparathyroidism.

Materials and methods. A female patient aged 51 years sought medical advice for complaints of spinal column and bone pains, periodic dizziness, and hand numbness. The patient underwent clinical and biochemical blood tests, determination of the blood levels of calcium, phosphorus, parathyroid hormone, concentrations of total vitamin D, calciuria, electrocardiography, thyroid ultrasonography, and neck computed tomography.

Results. Based on her complaints, examination evidence, evaluation of the clinical presentations of the disease, and objective and instrumental examination findings, the patient was diagnosed with left parathyroid adenoma and primary hyperparathyroidism; stage II hypertensive disease, grade I, a moderate risk; retinal angiopathy of both eyes; stage I dyscirculatory encephalopathy with liquor and venous dyscirculation and moderate vestibular ataxia; urolithiasis; kidney stones; and spondylosis mainly involving the lumbar spine. The diagnostic determinants for verifying the diagnosis were the results of neck computed tomography, namely: the signs of space-occupying lesion in the projection of the left parathyroid gland; the blood level of parathyroid hormone 118.6 pg/ml (normal value (N) 9.5–75.0 pg/ml); total vitamin D 21.64 nmol/l (N 75–250 nmol/l); and calcium 2.48 mmol/l (N 2.15–2.50 mmol/l). The history of urolithiasis, repeated lithotripsy, as well as spondylosis with lumboischalgia was an absolute indication for surgical treatment.

Conclusion. The practical interest in this case is due to the complexity of diagnosing normocalcemic hyperparathyroidism after vitamin D deficiency. The early stages of primary hyperparathyroidism are asymptomatic and frequently give rise to irreversible renal complications, causing renal failure and, as a consequence, disability. This clinical case demonstrates the importance of routinely determining vitamin D concentrations, which in turn triggers parathyroid adenomas.

1. Johansson H. The Uppsala anatomist Ivar Sandström and the parathyroid gland. Ups J Med 2015;120(2):72–7.

2. Выродов К.С., Архипов О.И., Бондаренко А.Г. и др. Трудности в диагностике и хирургическом лечении первичного гиперпаратиреоза. Кубанский научный медицинский вестник 2009;9(114): 20–2. [Vyrodov K.S., Arkhipov O.I.,

3. Bondarenko A.G. Difficulties in diagnostics and surgical treatment of the primary hyperparathyroidism. Kubanskiy nauchnyy meditsinskiy vestnik = Kuban Scientific Medical Herald 2009;9(114):20–2. (In Russ.)].

4. Пинский С.Б., Цмайло В.М., Федорова О.А. Ошибки и трудности в диагностике и лечении первичного гиперпаратиреоза. Сибирский медицинский журнал 2008;79(4):23–8. [Pinskiy S.B., Tsmaylo V.M., Fedorova O.A. Mistakes and difficulties in the diagnostics and treatment of the primary hyperparathyroidism. Sibirskiy meditsinskiy zhurnal = Siberian Medical Journal 2008; 79(4):23–8. (In Russ.)].

5. Очерки клинической эндокринологии. Под ред.: Ю.И. Караченцева, А.В. Казакова, Н.А. Кравчун, И.М. Ильиной. Харьков: С.А.М., 2011. [Essays in clinical endocrinology. Eds. by: Yu.I. Karachentsev, A.V. Kazakov, N.A. Kravchun, I.M. Il’ina. Khar’kov: S.A.M., 2011. (In Russ.)].

6. Эндокринология. Национальное руководство. Под ред.: И.И. Дедова, Г.А. Мельниченко. М.: ГЭОТАР-Медиа, 2013. [Endocrinology. National guidelines. Eds. by: I.I. Dedov, G.A. Mel’nichenko. Moscow: GEOTAR-Media, 2013. (In Russ.)].

7. Adami S., Marcocci C., Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 2002;17 Suppl 2:N18–23.

8. Хирургические болезни. Под ред. М.И. Кузина. М.: Медицина, 2002. [Surgical diseases. Eds. by М.I. Kuzin. Мoscow: Меditsina, 2002. (In Russ.)].

9. Камінський О.В., Афанасьєв Д.Є., Коваленко О.М. Стандарти надання медичної допомоги хворим з патологічними станами щітоподібної залози в умовах дії негативних чинників довкілля. Метод. посіб. Кіїв: День Печати, 2012. [Kaminskiy О.V., Аfanas’ev D.Е., Kovalenko О.М. Standards of medical assistance for patients with thyroid gland pathologies with negative environmental impacts. Меthodological rationale. Кiev: Den’ Pechati, 2012. (In Ukr.)].

10. Мокрышева Н.Г. Первичный гиперпаратиреоз: современное представление о проблеме. Лечение и профилактика 2013;2(6):143–52. [Mokrysheva N.G. Primary hyperparathyroidism: modern perception of the problem. Lechenie i profilaktika = Treatment and Prophylactics 2013;2(6): 143–52. (In Russ.)].

11. Bilezikian J.P., Silverberg S.J. Clinical spectrum of primary hyperparathyroidism. Rev Endocr Metab Disord 2000;1(4):237–45.

12. Аристархов В.Г. Редкие клинические наблюдения. Сборник научных трудов. Под ред. В.Г. Аристархова. Рязань: РИО РязГМУ, 2010. [Аristarkhov V.G. Rare case studies. Volume of scientific works. Eds. by: V.G. Аristarkhov. Ryazan’: RIO RyazGMU, 2010. (In Russ.)].

13. Bilezikian J.P., Potts J.T. Jr, Fuleihan Gel-H. et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 2002; 17 Suppl 2:N2–11.

14. Shah V.N., Shah C.S., Bhadada S.K., Rao D.S. Effect of 25(OH)D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH)D, calcium and PTH levels: a meta-analysis and review of literature. Clin Endocrinol (Oxf) 2014;80(6):797–803.

15. Черенько С.М. Диференціальна діагностика вузлових утворень щитовидної залози. Лікарська справа 1998;(6):136–40. [Cheren’ko S.М. Differential diagnostics of palpable abnormalities of the thyroid gland. Vrachebnoe delo = Medical Business 1998;(6):136–40. (In Ukr.)].